GFP-tagged Rabs (green) were co-transfected with WT or mutant neurolastin-HA (red) and co-localization was analyzed by immunostaining. ER and mitochondria were visualized by staining with α-KDEL and α-ATP5A antibodies, respectively. Scale bar, 10 µm. Neurolastin H97W colocalizes with the mitochondrial marker.
FIGURE S4. Presence of neurolastin in different subcellular fractions, related to See experimental procedures for detailed protocols.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Constructs and reagents used
Mouse neurolastin cDNA (NP_033574.2) was obtained from Open Biosystems. Fulllength neurolastin (1-654) was PCR amplified and subcloned with a C-terminal HA tag into pcDNA for localization in Hela cells. C-terminal HA-and N-terminal Flag-tagged neurolastin were cloned into pCAG and pCMV vectors, respectively for use in imaging and biochemical experiments. Truncations of neurolastin were generated by PCR amplification and cloned with a C-terminal HA tag in pCAG vector. Point mutations were generated using the quick-change mutagenesis protocol (Agilent Technologies). The plasmids were sequenced to confirm introduction of the required mutation. HA-Atlastin was generously provided by Dr. Craig Blackstone (NINDS, NIH). Different GFP-tagged endosomal markers (Rab 7, Rab 9 and Rab 11) and YFP-EEA1 were obtained from Dr.
Juan S. Bonifacino (NICHD, NIH). GFP-Rab 5 was a kind gift from Dr. Julie G.
Donaldson (NHLBI, NIH). A custom antibody was raised against the C-terminus of
neurolastin (aa 635-654) as described previously (Pao et al., 2011) by New England Peptide, and the serum was affinity purified on the peptide column. We also raised an antibody against the N-terminus (data not shown) of neurolastin. However, both antibodies recognize non-specific proteins. α-GluN1 antibody (clone 54.2) was generated by Dr. S.F. Heinemann and has been described previously (Brose et al., 1994) . Other antibodies used in the study for immunoblotting were purchased from different sources as listed: Monoclonal α-Flag, α-Tubulin, α-Synaptophysin, α-GluN2A, and α-GluN2B from Sigma, Polyclonal α-HA (Abcam), Monoclonal α-Myc (Cell signaling), α-FK1 (Enzolife sciences), α-GluA1 and α-GluA2 (Millipore), α-PSD-95 (Thermo Scientific), and α-SAP102 (Neuromab). PEI Cellulose F plates for the GTPase assay were purchased from Merck. Reagents for the E3 ligase activity assays were purchased from Enzo Life Sciences. Purified E1 was from Calbiochem. Monoclonal α-EEA-1 for labeling endosomes in neuronal cultures was purchased from BD Biosciences.
Multiple sequence alignment was generated using the ClustalW2 server online tool (Larkin et al., 2007) . Transmembrane domains were predicted using TM pred (K. Hofmann, 1993) and PSORTII (Nakai and Horton, 1999) . The coiled-coil region for neurolastin was predicted by COILS (Lupas et al., 1991) and the hydropathy plot was generated using ProtScale (Elisabeth Gasteiger and Séverine Duvaud, 2005) .
Biochemical characterization
Protein purification: Neurolastin (71-563) was cloned into pGEX4T1 to generate a GST- Membrane association: Membrane association of neurolastin was determined as described previously (Zhu et al., 2003) . Briefly, HEK293T cells were transfected with HA-tagged neurolastin or HA-tagged atlastin. The cells were re-suspended in buffer containing 10 mM Tris (pH 7.5), 10 mM NaCl, and 1.5 mM MgCl 2 and centrifuged at 1,330 x g for 10 min to remove the nuclei. The post nuclear supernatant (PNS) was sonicated and centrifuged at 130,000 x g for 2 h at 4°C to separate the cytosolic and membrane fraction. To separate the integral and peripheral membrane proteins, the membrane fraction obtained above was lysed in 1% Tx-114 containing buffer for 60 min at 4°C as described previously (Zhu et al., 2003) . Subsequently, the lysate was transferred to 37°C for 3 min and centrifuged at 10,000 x g for 1 min to separate proteins in the detergent phase (integral membrane proteins) and aqueous (peripheral membrane proteins) phase. 3% of each of the fractions was resolved by SDS-PAGE and immunoblotted with α-HA antibody.
Co-immunoprecipitation: HEK293T cells were cotransfected with Flag-Neurolastin and
Neurolastin-HA using Lipofectamine 2000 (Invitrogen) following manufacturer's instructions. 24 h after transfection, cells were lysed in PBS containing 1% Tx-100. The lysate was prepared by centrifugation at 16,000 x g for 15 min at 4°C. Lysates were incubated with HA-agarose beads (Sigma) for 3 h at 4°C, and washed with PBS containing 0.1% Tx-100 to remove non-specific protein and immunoblotted.
Generation and characterization of neurolastin antibody and KO mice
Neurolastin KO mice were generated in which the complete neurolastin coding sequence was replaced with a lacZ reporter. Neurolastin KO ES cells were available through a NIH funded project, The Knockout Mouse Consortium (KOMP). The ES cells were used to generate the neurolastin KO mice with the help of Dr. James Pickel and the NIMH transgenic facility. The initial confirmation of the mice genotypes was done by PCR amplification using multiple primers that are upstream of the neurolastin gene and within coding regions of the neurolastin or LacZ genes. We also confirmed that neurolastin is deleted in the KO mouse by Western blot analysis of brain lysates from WT and KO mice using a custom antibody raised against neurolastin. Brains from adult WT and KO animals were dissected and homogenized in buffer containing 10 mM Tris pH 7.5, 1 mM EDTA, 1 mM EGTA and 1 mM Na 3 VO 4 , 0.32 M sucrose and protease inhibitors.
Subsequently, PNS was collected by centrifugation of the homogenate at 1000 x g for 10 min at 4°C. 50 µg of PNS from both WT and KO animals were resolved by SDS-PAGE and subjected to immunoblotting. For detailed phenotypic examination, animals (3 adult WT and KO) were sent out to NIH Phenotyping Core. The facility conducted hematology, blood chemistry and organ examination. The use and care of animals in this study followed the guidelines of the NIH Animal Research Advisory Committee.
Immunofluorescence microscopy
HeLa cells were transfected with neurolastin-HA using CalPhos mammalian transfection kit (Clontech) following manufacturer's instructions. Staining was performed using standard procedures at RT. 24 h after transfection, the cells were fixed with 4% paraformaldehyde for 20 min followed by permeabilization with 0.25% Tx-100 for 20 min. Subsequently, the cells were blocked in 10% normal goat serum (NGS) for 30 min, and stained with α-HA using the method described above.
Fractionation
Biochemical fractionation was carried out following standard methods (Hallett et al., 2008) . Briefly brains from WT or KO mice (P15-16 littermates) were homogenized in cold TEVP buffer (10 mM Tris pH 7.5; 1 mM EDTA; 1 mM EGTA and 1 mM Na 3 VO 4 ) containing 0.32 M sucrose and protease inhibitors. The homogenate was centrifuged at 1000 x g for 10 min at 4°C to remove nuclei and large debris. The isolated PNS was centrifuged to 10,000 x g to obtain the crude synaptosomal (P2) fraction. P2 was incubated in hypo-osmotic solution (20 mM Tris pH 8.8, 5 mM EDTA, 1 mM Na 3 VO 4 )
for 20 min on ice and centrifuged for 30 min at 25,000 x g at 4°C to obtain synaptic plasma membranes (LP1). The supernatant, LS1 was centrifuged at 165,000 x g for 2 h to obtain the synaptic vesicle enriched fraction (LP2). LP1 was re-suspended in TEVP buffer containing 2% Tx-100 and incubated on ice for 15 min to lyse the SPM. SPM solubilized by Tx-100 were separated by centrifugation at 33,000 x g for 30 min at 4°C.
The pellet fraction obtained was subsequently solubilized in 1% SDS for 30 min at 37°C
and analyzed 10 µg total protein was used to analyze the levels of different proteins.
Levels of different proteins were compared for 3 independent sets of animals. ImageJ was used to quantitate the relative amount of protein by densitometry and the levels of each protein were normalized to tubulin levels in respective lanes. An unpaired two-tailed ttest was used to determine the significance of the data.
Golgi staining
Brains from WT and neurolastin KO animals (P25-30) were stained using FD Rapid
GolgiStain kit (FD NeuroTechnologies). Tissue was prepared as per the manufacturer's directions and frozen in 2-methylbutane. 100 µm sections were cut using Microtome HM 500 OM Cryostat at −30/32°C. The sections were dried and stained as per the manufacturers instructions and mounted using Permount Mounting Media (Fisher Scientific). Images were obtained using a 63X objective of a light microscope and analyzed using Metamorph. The number of spines per 10 µm length of secondary/tertiary dendrite were counted. An unpaired two-tailed t-test was used to determine the significance of the data.
Electrophysiology
Transverse 300 µm hippocampal slices were cut from P14-P18 WT and neurolastin KO mice on a DSK linear slicer vibratome in cutting solution containing 2.5 mM KCl, 0.5 mM CaCl 2 , 7 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 7 mM glucose, 1.3 mM ascorbic acid and 210 mM sucrose. Freshly cut slices were placed in an incubating chamber containing artificial cerebrospinal fluid (ACSF) [119 mM NaCl, 2.5 mM KCl, 26.2 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 11 mM glucose, 2.5 mM CaCl 2 , and 1.3 mM Synaptic responses were collected with a Multiclamp 700B amplifier (Axon Instruments), filtered at 2 kHz and digitized at 10 kHz. Paired-pulse ratios were measured by giving two pulses at a 50 ms interval and taking the ratio of the two peaks of the EPSCs from an average of 20-50 sweeps. All pharmacological reagents were purchased from Abcam, and other chemicals were purchased from Sigma. An unpaired two-tailed ttest was used to determine the significance of the data, and the data are presented as mean ± SEM from three independent blinded experiments with 3-7 neurons recorded in each mice.
